Effect of Uterine Manipulator on Recurrence and Mortality of Endometrial Cancer
1 other identifier
observational
951
0 countries
N/A
Brief Summary
The investigators sought to retrospectively assess whether the use of a intrauterine device to manipulate the uterus does affect the long-term oncologic outcomes of patients operated by laparoscopy for endometrial cancer
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Oct 2016
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2016
CompletedFirst Submitted
Initial submission to the registry
October 22, 2016
CompletedFirst Posted
Study publicly available on registry
October 25, 2016
CompletedNovember 15, 2016
November 1, 2016
Same day
October 22, 2016
November 14, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Disease recurrence
Relapse of disease during follow-up
4 years
Secondary Outcomes (2)
disease specific survival
4 years
overall survival
4 years
Study Arms (2)
MANIPULATOR
Patients who were operated for endometrial cancer by laparoscopy with the use of a uterine manipulator
NO MANIPULATOR
Patients who were operated for endometrial cancer by laparoscopy without the use of a uterine manipulator
Interventions
Patients were operated laparoscopically with the aid or not of an intrauterine probe to manipulate the uterus
Eligibility Criteria
Women affected by early endometrial cancer
You may qualify if:
- Clinical stage I endometrial cancer
- Laparoscopic operation
You may not qualify if:
- post-operative oncologic follow-up \< 12 months
- extra-uterine evidence of disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (2)
Marcos-Sanmartin J, Lopez Fernandez JA, Sanchez-Paya J, Pinero-Sanchez OC, Roman-Sanchez MJ, Quijada-Cazorla MA, Candela-Hidalgo MA, Martinez-Escoriza JC. Does the Type of Surgical Approach and the Use of Uterine Manipulators Influence the Disease-Free Survival and Recurrence Rates in Early-Stage Endometrial Cancer? Int J Gynecol Cancer. 2016 Nov;26(9):1722-1726. doi: 10.1097/IGC.0000000000000808.
PMID: 27518143BACKGROUNDTinelli R, Cicinelli E, Tinelli A, Bettocchi S, Angioni S, Litta P. Laparoscopic treatment of early-stage endometrial cancer with and without uterine manipulator: Our experience and review of literature. Surg Oncol. 2016 Jun;25(2):98-103. doi: 10.1016/j.suronc.2016.03.005. Epub 2016 Mar 23.
PMID: 27312035BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Stefano Uccella
Università degli Studi dell'Insubria
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Doctor
Study Record Dates
First Submitted
October 22, 2016
First Posted
October 25, 2016
Study Start
October 1, 2016
Primary Completion
October 1, 2016
Study Completion
October 1, 2016
Last Updated
November 15, 2016
Record last verified: 2016-11
Data Sharing
- IPD Sharing
- Will not share